Ovarian metastases from extragenital neoplasms are rare. The prevalent sites of the primary tumors were the breast, colorectum and the stomach. The Krukenberg tumor (KT) is defined as a gastrointestinal cancer which metastasized to the ovaries. Metastasis to the ovary may appear at the time of diagnosis of the primary tumor (synchronous) or during observation (metachronous). Common clinical presentations are abdominal distention, pain, palpable mass, bloating, ascites or pain during sexual intercourse. Diagnosis can be made by ultrasound examinations, CT or EMR scans, laparotomy and/or a biopsy of the ovary. The current standard treatment for patients with metastatic gastric cancer is systemic chemotherapy, however, treatment strategy for KTs from gastric cancer has not been clearly established and surgical treatment is considered mainly for metachronous tumors. The prognosis of patients with ovarian metastasis of gastric cancer origin is poorer compared with that of other primary tumors. Although the results of cytoreductive surgery – especially in combination with modern chemotherapy – seems to be promising, the optimal therapeutic strategies for such patients requires further prospective studies.
1. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 2010;17:3077-9.
2. Fujiwara Y, Doki Y, Taniguchi H, et al. Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives. Gastric Cancer 2007;10:197-204.
3. Sugarbaker PH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care. Cancer Treat Rev 2016;48:42-9.
4. Mazur MT, Hsueh S, Gersell DJ. Metastases to the female genital tract. Analysis of 325 cases. Cancer 1984;53:1978-1984.
5. de Waal Y, Thomas C, Oei A, et al. Secondary ovarian malignancies: Frequency, origin, and characteristics. Int J Gynecol Cancer 2009;19: 1160-65.
6. Skírnisdóttir I, Garmo H and Holmberg L: Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: Occurrence, origin and survival compared to ovarian cancer. Gynecol Oncol 2007;105:166-71.
7. Moore RG, Chung M, Granai CO, et al: Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol 2004;93:87-91.
8. Turan T, Aykan B, Koc S, et all. Analysis of metastatic ovarian tumors from extragenital primary sites. Tumori 2006;92:491-5.
9. Yada-Hashimoto N, Yamamoto T, Kamiura S, et al. Metastatic ovarian tumors: A review of 64 cases. Gynecol Oncol 2003;89:314-17.
10. Hishikawa K, Nagura M, Kim T, et al: Pathways of metastases from primary organs to the ovaries. Obstet Gynecol Int 2011:612817
11. Bang Y. Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma. Cancer 1999; 85:1490-99.
12. Feng Q, Pei W, Zheng Z et al. Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis. Cancer Biol Med. 2013;10:86-91.
13. Kim W, Kim T, Kim S et al.The role of cytoreductive surgery for nongenital tract metastatic tumors to the ovaries. Eur J Obstet Gynecol Reprod Biol 2010; 149:97-101.
14. Ulbright T, Roth L, Stehman F. Secondary ovarian neoplasia. A clinicopathologic study of 35 cases. Cancer 1984;53:1164-74.
15. Kobayashi O, Sugiyama Y, Cho H et al. Clinical and pathological study of gastric cancer with ovarian metastasis. Int J Clin Oncol 2003;8:67-71.
16. Miller B, Pittman B, Wan J et al. Colon cancer with metastasis to the ovary at time of initial diagnosis. Gynecol Oncol 1997;66:368-71.
17. Rosa F, Marrelli D, Morgagni P et al. Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience. World J Surg 2016; 40:921-28.
18. Skírnisdóttir I, Garmo H, Holmberg L. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: Occurrence, origin and survival compared to ovarian cancer. Gynecol Oncol 2007; 105:166-7.
19. Papakonstantinou E, Liapis A, Kairi-Vassilatou E et al. Virilizing ovarian Krukenberg tumor in a 27-year-old pregnant woman. A case report and literature review. Eur J Gynaecol Oncol 2011;32:331-3.
20. Kiyokawa T, Young RH, Scully RE. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol. 2006;30:277-99.
21. Al-Agha OM and Nicastri AD. An in-depth look at Krukenberg tumor: An overview. Arch Pathol Lab Med. 2006;130:1725-30.
22. Jun S-Y, Park J. Metachronous Ovarian Metastases Following Resection of the Primary Gastric Cancer. J Gastric Cancer 2011;11: 31-7.
23. Matsushita H, Watanabe K, Wakatsuki A. Metastatic gastric cancer to the female genital tract. Mol Clin Oncol. 2016;5:495-99.
24. Lu L, Shao Y, Hsu C et al. Metastasectomy of Krukenberg tumors may be associated with survivalbenefits in patients with metastatic gastric cancer. Anticancer Res. 2012;32:3397-401.
25. Cho JH, Lim JY, Choi AR et al. Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg. Cancer Res Treat 2015;47:697-705.
26. Brieau B, Auzolle C, Pozet A, et al. Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study. Dig Liver Dis 2016;48:441-45.
27. Wu XJ, Yuan P, Li ZY et al: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination. Tumour Biol. 2013;34:463-9.